ZIVO Bioscience
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of ZIVO Bioscience generated cash of -$5,799,893, which is more than the previous year. Cash used in financing activities reached the amount of $4,275,010 last year. Net change in cash is therefore -$1,524,883.
Cash Flow
| 2014 | -2.73M | 0 | 2.24M |
|---|---|---|---|
| 2015 | -2.29M | 0 | 2.31M |
| 2016 | -2.54M | 0 | 3.03M |
| 2017 | -4.24M | 0 | 4.05M |
| 2018 | -5.00M | 0 | 5.07M |
| 2019 | -3.70M | 0 | 3.66M |
| 2020 | -2.58M | 0 | 2.38M |
| 2021 | -6.80M | 0 | 15.56M |
| 2022 | -7.10M | 0 | -628.6K |
| 2023 | -5.79M | 0 | 4.27M |
ZIVO Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.79M | 8.90M | 137.86K | 346.11K | 388.89K | 317.13K | 506.98K | 16.58K | 1.38K | 493.10K |
Operating activities | ||||||||||
Net income | -7.77M | -8.74M | -9.16M | -9.10M | -11.51M | -14.63M | -10.03M | -6.05M | -5.78M | 680.81K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 439.59K | -774.02K | -555.74M | 0 | 1.18M | 5.09M | 18.75K | 25K | 25K | 29.83K |
Stock-based compensation expense | 867.35K | 2.69M | 2.97M | 1.24M | 3.60M | 0 | 2.61M | 1.29M | 397.99K | 139.27K |
| Deferred income tax benefit | 867.35K | 2.69M | 2.97M | 1.24M | 3.60M | 0 | 2.61M | 1.29M | 397.99K | 139.27K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -3.73K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 118.46K |
Inventories | 1.10M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 675.09K | -163.66K | -905.29K | 187.19K | 950.00K | -119.28K | -124.65K | -448.06K | 100.07K | 744.27K |
Cash generated by operating activities | -5.79M | -7.10M | -6.80M | -2.58M | -3.70M | -5.00M | -4.24M | -2.54M | -2.29M | -2.73M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 640K | 0 | 17.20M | 400.86K | 2.65M | 3.43M | 0 | 0 | 48.5K | 735.5K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -190.5K | -250.7K | 32.5K | -217.61K | 4.14M | -91.13K | 2.26M | -141.01K |
Cash used in financing activities | 4.27M | -628.6K | 15.56M | 2.38M | 3.66M | 5.07M | 4.05M | 3.03M | 2.31M | 2.24M |
Net Change In Cash | -1.52M | -7.10M | 8.76M | -208.24K | -42.78K | 71.75K | -189.85K | 490.39K | 15.20K | -491.72K |
Cash at end of period | 274.38K | 1.79M | 8.90M | 137.86K | 346.11K | 388.89K | 317.13K | 506.98K | 16.58K | 1.38K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |